Table D71: Brachytherapy — Lymphatic and Hematologic System
Row 1
- Treatment Site:
0 Bone Marrow; 1 Thymus; 2 Spleen; 3 Lymphatics, Neck; 4 Lymphatics, Axillary; 5 Lymphatics, Thorax; 6 Lymphatics, Abdomen; 7 Lymphatics, Pelvis; 8 Lymphatics, Inguinal - Modality Qualifier:
9 High Dose Rate (HDR) - Isotope:
7 Cesium 137 (Cs-137); 8 Iridium 192 (Ir-192); 9 Iodine 125 (I-125); B Palladium 103 (Pd-103); C Californium 252 (Cf-252); Y Other Isotope - Qualifier:
Z None
Row 2
- Treatment Site:
0 Bone Marrow; 1 Thymus; 2 Spleen; 3 Lymphatics, Neck; 4 Lymphatics, Axillary; 5 Lymphatics, Thorax; 6 Lymphatics, Abdomen; 7 Lymphatics, Pelvis; 8 Lymphatics, Inguinal - Modality Qualifier:
B Low Dose Rate (LDR) - Isotope:
6 Cesium 131 (Cs-131); 7 Cesium 137 (Cs-137); 8 Iridium 192 (Ir-192); 9 Iodine 125 (I-125); C Californium 252 (Cf-252); Y Other Isotope - Qualifier:
Z None
Row 3
- Treatment Site:
0 Bone Marrow; 1 Thymus; 2 Spleen; 3 Lymphatics, Neck; 4 Lymphatics, Axillary; 5 Lymphatics, Thorax; 6 Lymphatics, Abdomen; 7 Lymphatics, Pelvis; 8 Lymphatics, Inguinal - Modality Qualifier:
B Low Dose Rate (LDR) - Isotope:
B Palladium 103 (Pd-103) - Qualifier:
1 Unidirectional Source; Z None